Atlas Trials

Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid

Clinical trial NCT03735537 · COMPLETED

Trial details

NCT number
NCT03735537
Sponsor
University of Edinburgh
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Osteogenesis Imperfecta
Start date
2016-11-01
Primary completion
2025-02-28
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.